Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
138.60
+3.66 (2.71%)
At close: Aug 15, 2025, 4:00 PM
139.59
+0.99 (0.71%)
After-hours: Aug 15, 2025, 7:58 PM EDT
Biogen (BIIB) Revenue by Segment
History
| Date | Multiple Sclerosis | Other | Rare Disease | Biosimilars |
|---|---|---|---|---|
| Jun 30, 2025 | 4.18B | 2.85B | 2.14B | 761.10M |
| Mar 31, 2025 | 4.23B | 2.64B | 2.13B | 777.50M |
| Dec 31, 2024 | 4.35B | 2.49B | 1.99B | 793.60M |
| Sep 30, 2024 | 4.45B | 2.39B | 1.87B | 779.80M |
| Jun 30, 2024 | 4.55B | 2.42B | 1.82B | 777.50M |
| Mar 31, 2024 | 4.61B | 2.47B | 1.72B | 774.50M |
| Dec 31, 2023 | 4.66B | 2.59B | 1.74B | 770.00M |
| Sep 30, 2023 | 4.76B | 2.67B | 1.79B | 756.60M |
| Jun 30, 2023 | 4.94B | 2.50B | 1.77B | 749.90M |
| Mar 31, 2023 | 5.16B | 2.42B | 1.76B | 749.20M |
| Dec 31, 2022 | 5.43B | 2.19B | 1.79B | 751.10M |
| Sep 30, 2022 | 5.69B | 2.09B | 1.78B | 797.20M |
| Jun 30, 2022 | 5.91B | 2.11B | 1.79B | 812.40M |
| Mar 31, 2022 | 6.01B | 2.12B | 1.86B | 820.40M |
| Dec 31, 2021 | 6.10B | 2.13B | 1.91B | 831.20M |
| Sep 30, 2021 | 6.17B | 2.15B | 1.96B | 807.80M |
| Jun 30, 2021 | 6.60B | 2.26B | 2.01B | 812.90M |
| Mar 31, 2021 | 7.20B | 2.61B | 2.01B | 782.10M |
| Dec 31, 2020 | 7.83B | 2.75B | 2.05B | 795.80M |
| Sep 30, 2020 | 8.41B | 2.95B | 2.10B | 794.20M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.